Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: exploratory analysis of the proportional hazards assumption.
Saved in:
| Title: | Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: exploratory analysis of the proportional hazards assumption. |
|---|---|
| Authors: | Yajima S; Department of Urology, National Cancer Center Hospital East, Kashiwa, Japan., Yoshida S; Department of Urology, Institute of Science Tokyo, Tokyo, Japan., Masuda H; Department of Urology, National Cancer Center Hospital East, Kashiwa, Japan., Fujii Y; Department of Urology, Institute of Science Tokyo, Tokyo, Japan. |
| Source: | Translational andrology and urology [Transl Androl Urol] 2026 May 30; Vol. 15 (5), pp. 189. Date of Electronic Publication: 2026 May 15. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: AME Pub Country of Publication: China NLM ID: 101581119 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2223-4691 (Print) Linking ISSN: 22234683 NLM ISO Abbreviation: Transl Androl Urol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2223-4691 |
|---|---|
| DOI: | 10.21037/tau-2026-1-0104 |
